Tobi and Levaquin drug interactions - from FDA reports


Drug interactions are reported among people who take Tobi and Levaquin together. This study is created by eHealthMe based on reports of 43 people who take Tobi and Levaquin from FDA, and is updated regularly.

How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.

Who is eHealthMe: we are a data analysis company who specializes in health care industry. Our original studies have been referenced on 500+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and EANO. On eHealthMe, you can research drugs and monitor them (see testimonials).



On Oct, 18, 2018

43 people who take Tobi, Levaquin are studied.


Number of reports submitted per year:

Tobi and Levaquin drug interactions.

Most common drug interactions over time *:

< 1 month:
  1. Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)
  2. Pyrexia (fever)
  3. Cough
  4. Abdominal pain upper
  5. Influenza
1 - 6 months:
  1. Cough
  2. Chest discomfort
  3. Constipation
  4. Contusion (a type of hematoma of tissue in which capillaries)
  5. Dehydration (dryness resulting from the removal of water)
6 - 12 months:

n/a

Click here to view more results or personalize the results to your gender and age

Most common drug interactions by gender *:

female:
  1. Forced expiratory volume decreased (decreased lung expired air volume)
  2. Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection)
  3. Fatigue (feeling of tiredness)
  4. Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
  5. Asthma
male:
  1. Pyrexia (fever)
  2. Hypotension (abnormally low blood pressure)
  3. Apparent death (playing dead)
  4. Arthralgia (joint pain)
  5. Asthenia (weakness)

Click here to view more results or personalize the results to your gender and age

Most common drug interactions by age *:

0-1:

n/a

2-9:
  1. Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)
  2. Abdominal pain upper
  3. Influenza
  4. Asthma
  5. Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection)
10-19:
  1. Back pain
  2. Cellulitis (infection under the skin)
  3. Cough
  4. Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)

Click here to view more results or personalize the results to your gender and age

* Approximation only. Some reports may have incomplete information.

FDA reports used in this study



Do you take Tobi and Levaquin?


You are not alone:




Related studies

Tobi

Tobi has active ingredients of tobramycin. (latest outcomes from Tobi 6,728 users)

Levaquin

Levaquin has active ingredients of levofloxacin. It is often used in sinusitis. (latest outcomes from Levaquin 45,711 users)


Interactions between Tobi and drugs from A to Z
a b c d e f g h i j k l m n o p q r s t u v w x y z
Interactions between Levaquin and drugs from A to Z
a b c d e f g h i j k l m n o p q r s t u v w x y z
Browse all drug interactions of Tobi and Levaquin
a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies

What would happen?

Predict new side effects and undetected conditions when you take Tobi and Levaquin (7,827 reports studied)

Recent updates

Recent general studies
Recent personal studies

NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.